MedTech Dive August 13, 2024
Nick Paul Taylor

Medtronic said Monday it is the first company to receive FDA approval to offer DBS surgery while a patient is asleep or awake.

Dive Brief:

  • Medtronic said Monday it received Food and Drug Administration approval for deep brain stimulation (DBS) technology that is implanted while the patient is under general anesthetic.
  • Surgeons traditionally perform DBS procedures, a treatment for medical conditions like epilepsy and Parkinson’s disease, while the patient is awake. However, a series of studies have shown there may be benefits to putting the patient to sleep for the procedure.
  • Medtronic said it is the first company to receive FDA approval to offer DBS surgery while a patient is asleep or awake. U.S. surgeons have used DBS devices...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Medical Devices
Medtronic buys surgical instrument developer Fortimedix
Shippable ‘Health Cube’ Hospital In A Box Integrates With 400 Medical Devices
Med tech industry uses global reach to compete for innovation leadership at MEDICA and COMPAMED
Medtronic reports higher quarterly revenue, raises sales outlook for 2025
Decisions that could impact medical devices under Trump administration: 4 notes

Share This Article